4.5 Article

Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins

Journal

PROTEOMICS
Volume 11, Issue 23, Pages 4578-4582

Publisher

WILEY
DOI: 10.1002/pmic.201000744

Keywords

Antibody microarrays; Chromatographic enrichment; Fluorescent labeling; Multiplexed proteomics technology; Protein arrays

Funding

  1. Norwegian Research Council (FUGE)
  2. University of Oslo
  3. Norwegian Cancer Society
  4. Norwegian Financial Mechanism [A/CZ0046/2/0008]
  5. EEA Financial Mechanism

Ask authors/readers for more resources

Antibody array analysis of complex samples requires capture reagents with exceptional specificity. The frequency of antibodies with label-based detection may be as low as 5%. Here, however, we show that as many as 25% of commercially available antibodies are useful when biotinylated cellular proteins are fractionated by size exclusion chromatography (SEC) first. A microsphere multiplex with 1725 antibodies to cellular proteins was added to 24 SEC fractions, labelled with streptavidin and analyzed by flow cytometry (microsphere-based affinity proteomics, MAP) The SEC-MAP approach resolved different targets captured by each antibody as reactivity peaks across the separation range of the SEC column (10-670kDa). Complex reactivity profiles demonstrated that most antibodies bound more than one target. However, specific binding was readily detected as reactivity peaks common for different antibodies to the same protein. We optimized sample preparation and found that amine-reactive biotin rarely inhibited antibody binding when the biotin to lysine ratio was kept below 1: 1 during labelling. Moreover, several epitopes that were inaccessible to antibodies in native proteins were unmasked after heat denaturation with 0.1% of SDS. The SEC-MAP format should allow researchers to build multiplexed assays with antibodies purchased for use in e. g. Western blotting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available